Clinical use of vascular endothelial growth factor receptor inhibitors for the treatment of renal cell carcinoma
Wei Li, Chengguan Feng, Weihong Di, Shanwen Hong, Hui Chen, M. Ejaz, Yang Yang, Tian‐Rui Xu
Topics & Concepts
AxitinibSunitinibPazopanibSorafenibRenal cell carcinomaMedicineVascular endothelial growth factorCabozantinibTargeted therapyOncologyLenvatinibPharmacologyInternal medicineTemsirolimusTyrosine-kinase inhibitorCancer researchCancerVEGF receptorsSignal transductionBiologyPI3K/AKT/mTOR pathwayHepatocellular carcinomaDiscovery and development of mTOR inhibitorsBiochemistryRenal cell carcinoma treatmentRenal and related cancersVascular Tumors and Angiosarcomas